Abstract
References
- Topçu AW, Soyletir G, Doğanay ME, editors. Infectious diseases and microbiology. İstanbul: Nobel Medical Bookstores; 2017. p. 887-905.
- World Health Organization. World malaria report 2017, WHO Press, Geneva, Switzerland.
- Parlak E, Ertürk A, Çayır Y, Parlak M. Four malaria-import patterns: sporadic region. Turkiye Parazitol Derg 2013; 37: 161-7.
- World Health Organisation (WHO). Guidelines for the treatment of malaria. Second edition.2015.Availableat:https://www.who.int/malaria/publications/atoz/mpac_report_september_2014.pdf (Accessed on 3 July 2021).
- Ulçay A, Karaahmetoğlu G, Turhan V, et al. The management of therapeutic failure in a falciparum malaria patient under oral arthemether lumefantrine therapy. Turkiye Parazitol Derg 2014; 38: 61-7.
- Valecha N, Srivastava P, Mohanty SS, et al. Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India. Malar J 2009; 8: 107.
- Askling HH, Bruneel F, Burchard G, et al. Management of imported malaria in Europe. Malar J 2012; 11: 328.
- Bayındır Y, Aycan OM, Atambay M, et al. The first appearance in Malatya of falciparum malaria originating in Uganda: Two cases, Turkiye Parazitol Derg 2005; 29: 157-9.
Abstract
Malaria is an infectious disease caused by Plasmodium species parasites and transmitted to humans by the Anopheles mosquito. The malaria parasites responsible for infection in humans are Plasmodium vivax, Plasmodium ovale, Plasmodium falciparum, Plasmodium malaria, and Plasmodium knowlesi. Although malaria cases originating from Turkey no longer occur, cases originating from abroad are still seen. This report evaluates the epidemiological and clinical characteristics and histories of seven imported malaria cases. All seven cases in this report had a history of travel to African countries together with fever (>39°C), weakness, headache, tremor, sweating, cough, general body pain, and severe shortness of breath. Appropriate treatment was arranged once the necessary examinations had been performed. All patients but one responded to treatment. The non-responsive patient re-presented after 15 days with similar complaints. Primaquine therapy at 15 mg tablet 2×1 was administered, and that patient was discharged after 14 days. The most effective means of bringing malaria under control involves rapid diagnosis and effective treatment. We wish to emphasize that imported cases may be seen in non-endemic regions due to international travel. The travel history of patients in sporadic regions should be investigated, and malaria should be considered in the presence of fever in order to ensure early diagnosis and treatment.
References
- Topçu AW, Soyletir G, Doğanay ME, editors. Infectious diseases and microbiology. İstanbul: Nobel Medical Bookstores; 2017. p. 887-905.
- World Health Organization. World malaria report 2017, WHO Press, Geneva, Switzerland.
- Parlak E, Ertürk A, Çayır Y, Parlak M. Four malaria-import patterns: sporadic region. Turkiye Parazitol Derg 2013; 37: 161-7.
- World Health Organisation (WHO). Guidelines for the treatment of malaria. Second edition.2015.Availableat:https://www.who.int/malaria/publications/atoz/mpac_report_september_2014.pdf (Accessed on 3 July 2021).
- Ulçay A, Karaahmetoğlu G, Turhan V, et al. The management of therapeutic failure in a falciparum malaria patient under oral arthemether lumefantrine therapy. Turkiye Parazitol Derg 2014; 38: 61-7.
- Valecha N, Srivastava P, Mohanty SS, et al. Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India. Malar J 2009; 8: 107.
- Askling HH, Bruneel F, Burchard G, et al. Management of imported malaria in Europe. Malar J 2012; 11: 328.
- Bayındır Y, Aycan OM, Atambay M, et al. The first appearance in Malatya of falciparum malaria originating in Uganda: Two cases, Turkiye Parazitol Derg 2005; 29: 157-9.
Details
| Primary Language | English |
|---|---|
| Subjects | Health Care Administration |
| Journal Section | Case Report |
| Authors | |
| Publication Date | September 24, 2021 |
| Published in Issue | Year 2021 Volume: 3 Issue: 4 |
TR DİZİN ULAKBİM and International Indexes (1b)
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS]
Note: Our journal is not WOS indexed and therefore is not classified as Q.
You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/3449/file/4924/show
Journal Indexes and Platforms:
TR Dizin ULAKBİM, Google Scholar, Crossref, Worldcat (OCLC), DRJI, EuroPub, OpenAIRE, Turkiye Citation Index, Turk Medline, ROAD, ICI World of Journal's, Index Copernicus, ASOS Index, General Impact Factor, Scilit.The indexes of the journal's are;
|
|
|
|
The platforms of the journal's are;
|
|
|
|
The indexes/platforms of the journal are;
TR Dizin Ulakbim, Crossref (DOI), Google Scholar, EuroPub, Directory of Research Journal İndexing (DRJI), Worldcat (OCLC), OpenAIRE, ASOS Index, ROAD, Turkiye Citation Index, ICI World of Journal's, Index Copernicus, Turk Medline, General Impact Factor, Scilit
EBSCO, DOAJ, OAJI is under evaluation.
Journal articles are evaluated as "Double-Blind Peer Review"